August 2021 - Page 11 of 14

TuesdayAug 10, 2021 9:00 am

Mobius Interactive Ltd. Expands Globally – Targeting Emerging iGaming Markets

Mobius Interactive Ltd. is strategically targeting global iGaming hotspots with three unique brands Club Double is targeting the emerging iGaming market in India Mobius.bet is expanding rapidly in the Brazilian market, as a top television sponsor for both the 2021/22 World Cup Qualifiers and for Italian Serie A football in August 2021 Aragon Casino will target the regulated Canadian market Mobius Interactive, a Vancouver-based online gaming company, has three distinct brands: Mobius.bet , Club Double and Aragon Casino. Paired with unique design and style, each brand targets specific geographical regions and demographics—offering a diverse and innovative iGaming experience to a…

MondayAug 09, 2021 2:16 pm

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Subsidiary Inks Deal to Provide Limited-Edition Alkaline Spring Water to BC Firefighters

Naturo Group signs contract with BC Wildfire Services Division; will provide special bottled water to over 1,100 firefighters across British Columbia. TRACE-branded natural 7.7ph alkaline spring water is sourced directly the source in British Columbia, the very land the firefighters protect. BevCanna’s TRACE product line features unique, ancient minerals that offer a broad range of wellness properties including cognitive performance, immune function and gut health. BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) has announced that its wholly owned subsidiary Naturo Group has been selected to manufacture and supply a special, limited-edition run of its TRACE-branded, alkaline spring water to…

MondayAug 09, 2021 1:58 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Rolling out Rapid Disease Testing in Canada, Plans to Expand into US and UK Markets

Avricore Health has announced that it is ready to roll out its HealthTab rapid disease testing system in pharmacies across Canada The rapid disease testing system comprises two key components, Avricore’s web-based HealthTab and Abbott’s Affinion 2 multi-assay analyzer The global point-of-care diagnostics market was valued at $34.49 billion in 2020 and is expected to continue growing and reach $81.37 billion by 2028 Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), an innovator in pharmacy services focused on the acquisition and development of early-stage technology aimed to move pharmacies forward, is set to roll out its proprietary HealthTab rapid disease testing system…

MondayAug 09, 2021 1:46 pm

Flora Growth Corp. (NASDAQ: FLGC) Receives Fair Value Estimate, Coverage from Argus Research Company; Developing Growth Opportunities by Columbia’s Cannabis Law, Headquarter Relocation

Flora Growth Corp recently received coverage from Argus Research, which gives the company’s stock a fair value estimate of $7.50 against the $3.24 recorded July 20 Argus also projects that Flora’s revenue would increase to $9 million in 2021 and $31 million in 2022, up from $0.1 million reported in 2020 Flora received a boost in its operations when Colombia’s president accepted and signed reforms to the existing cannabis legislation The updated law allows for the manufacture, sale and export of psychoactive (high-THC) cannabinoid ingestible and medical products and removes marketing limitations on cannabis products in Colombia Flora is also…

MondayAug 09, 2021 1:12 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

MondayAug 09, 2021 12:09 pm

Brain Scientific Inc. (BRSF) Positioned to Disrupt EEG Market with Cost-Effective Brain Imaging Devices

Brain Scientific poised to disrupt neurology market with two new FDA-cleared patented products that provide cost-effective brain imaging in any setting Current global market for EEG devices estimated at $956.1 million with CAGR of 8.7% from 2019 to 2026, expected to reach $1.6 billion by 2026 With a focus on developing innovative and proprietary medical devices and software, Brain Scientific (OTCQB: BRSF), a commercial-stage health care company, is fulfilling its mission of modernizing and increasing accessibility to brain diagnostics with two new FDA-cleared products that provide next-generation solutions to the neurology market. Already patented in the United States, China and…

MondayAug 09, 2021 11:11 am

Friendable Inc. (FDBL) Announces Successful Launch of Fan Pass Streaming Artist Platform’s Version 2.0

The updated Fan Pass platform features a slew of upgrades including an updated web design and an enhanced user interface/user experience The monthly subscription for fans to access the Fan Pass platform is less than a digital download, only $2.99 per month for an All-Access VIP experience The company plans to add NFTs to its offering and has a signed Letter of Intent with Santo Blockchain Labs and Santo Mining Corp. Fan Pass will continue to monetize livestream events, merchandise and fan subscribers — increasing revenue opportunities for the artists who sign up for the platform Mobile technology and entertainment…

MondayAug 09, 2021 11:04 am

TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Voted Best New Product at First B2B Convention

TAAT flagship product also earned distinction as second runner-up to Best in Show. “Awards are excellent indicator of how product is received by an audience of buyers keen to embrace concepts such as ours,” says CEO. Trade shows are key pieces in company’s strategic plan to grow presence, awareness in the tobacco industry. In its first convention appearance since launching in October of last year, TAAT(TM) Global Alternatives’ (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) flagship product was named Best New Product and earned the second-highest honor as Best in Show. The company began a round of trade shows by participating…

FridayAug 06, 2021 9:30 am

Sharing Services Global Corp. (SHRG), Subsidiary Take Significant Step on Path to Empower Latino Brand Partners

Team is always looking for ways to support dedicated brand partners in growing their businesses New materials include Spanish-language sizzle videos, product-marketing assets and other sales tools Company recently announced plans to unveil entire U.S. product line to customers in 21 European countries Sharing Services Global (OTCQB: SHRG) and its subsidiary The Happy Co. have unveiled new Spanish-language resources to support the growing U.S. Latino market, as well as other Spanish-speaking countries around the globe (https://nnw.fm/5XaO4). The Happy Co. is a leading producer and distributor of nootropic, functional beverage products with a focus on health and wellness. “Our team is…

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: August 2021